Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from cirrhosis or risk for death in patients with decompensated cirrhosis, according to data ...
Please provide your email address to receive an email when new articles are posted on . Patients who received simvastatin plus rifaximin experienced similar rates of complications as those treated ...
CHICAGO, Nov 7 (Reuters) - A popular drug used to keep cholesterol in check might be interfering with a good night's sleep, U.S. researchers said on Wednesday. A large study looking at sleep patterns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback